↓ Skip to main content

Dove Medical Press

Carfilzomib for relapsed and refractory multiple myeloma

Overview of attention for article published in Cancer Management and Research, April 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
94 Mendeley
Title
Carfilzomib for relapsed and refractory multiple myeloma
Published in
Cancer Management and Research, April 2019
DOI 10.2147/cmar.s150653
Pubmed ID
Authors

K Groen, NWCJ van de Donk, CAM Stege, S Zweegman, IS Nijhof

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 94 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 17%
Student > Ph. D. Student 11 12%
Student > Bachelor 11 12%
Researcher 6 6%
Other 4 4%
Other 14 15%
Unknown 32 34%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 17 18%
Medicine and Dentistry 16 17%
Pharmacology, Toxicology and Pharmaceutical Science 7 7%
Agricultural and Biological Sciences 6 6%
Psychology 3 3%
Other 10 11%
Unknown 35 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2021.
All research outputs
#7,577,875
of 23,758,334 outputs
Outputs from Cancer Management and Research
#326
of 2,018 outputs
Outputs of similar age
#137,894
of 353,331 outputs
Outputs of similar age from Cancer Management and Research
#15
of 105 outputs
Altmetric has tracked 23,758,334 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 2,018 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,331 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 105 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.